Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,587,950
-
Total 13F shares
-
951,649
-
Share change
-
+951,649
-
Total reported value
-
$4,416,382
-
Price per share
-
$4.64
-
Number of holders
-
22
-
Value change
-
+$4,416,382
-
Number of buys
-
22
Institutional Holders of Aptose Biosciences Inc. - Common Shares (APTO) as of Q2 2023
As of 30 Jun 2023 Aptose Biosciences Inc. - Common Shares (APTO) had 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 951,649 shares of stock of the company.
Largest 10 holders included DRW Securities, LLC, Nantahala Capital Management, LLC, CARLSON CAPITAL L P, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, Voss Capital, LLC, US BANCORP \DE\, WELLS FARGO & COMPANY/MN, Gleason Group, Inc., and Royal Bank of Canada.
This table shows 22 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.